Trial intelligence / Profile preview

DANISH – Danish multicenter imaging and biomarker study in spondyloarthritis patients receiving Humira

2005-001826-99Phase 4Completed

Sponsor
Copenhagen University Hospital - Hvidovre
Start
Aug 2005
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

Phase 4, single-arm trial of adalimumab in spondyloarthritis (SpA), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: ASAS50 response at week 24. Started Aug 2005; status: completed.

02

Drugs

03

Conditions

spondyloarthritis (SpA)

Beyond the preview

Go deeper on 2005-001826-99.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001826-99.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call